The TCT 2022 Innovation Shark Tank Competition award presentation was held Sept. 19, in Boston, MA. Shown here announcing the winner, Puzzle Medical Devices, are Robert Schwartz, MD, and Juan F. Granada, President and CEO of the Cardiovascular Research Foundation (CRF).
September 19, 2022 — Puzzle Medical Devices, a provider of hemodynamic support in Heart Failure (HF), was selected as the winner of the TCT 2022 Innovation Shark Tank Competition. The award program was held during the TCT 2022 Conference on Monday, September 19, in Boston, MA. Puzzle Medical is a Canadian company specializing in the development of a minimally invasive long-term hemodynamic transcatheter pump. According to the company, Puzzle Medical enables mechanical hemodynamic support to increase accessibility, improve patient quality of life, and reduce the global economic burden related to the disease.
The TCT Innovation Shark Tank Competition is a global initiative designed to identify and promote the development of novel technologies having the potential to transform human health. The competition has been funded by the Jon DeHaan Foundation for Medical Innovation for the past five years. As described by the Foundation’s President, Robert Schwartz, MD, during the award ceremony, DeHaan benefitted personally from innovations in cardiovascular technology several times and, as a result, has been a strong philanthropic supporter of medical innovations, which led to the creation of this prestigious award.
A total of six companies participated in the competition, from which three finalists were selected. In addition to Puzzle Medical Devices, the two other finalists were Magneto Thrombectomy Solutions, a pulmonary embolism solution, and Solopace, a purpose build pacing system for TAVR. Other Shark Tank Competition participants this year included: Cardionomic, offering cardiac autonomic modulation therapy; Restore Medical, pulmonary banding for HF treatment; and NXT Biomedical, pulmonary to venous shunt for PH-HFpEF.
Judges and Advisors for the TCT 2022 Innovation Shark Tank Competition included the following (listed alphabetically): Louis A. Cannon, MD, Founder and Managing Director, Biostar Capital; Andrew Cleeland, CEO of Fogarty Innovation, Juan F. Granada, MD, President and CEO of CRF; Greg L. Kaluza, MD, PhD, Senior Research Director at Skirball Center for Innovation; Peter J. Fitzgerald, MD, PhD, Co-Founder and Managing Partner, TriVentures; Daniel Burkhoff, MD, PhD, Director, HF and Circulatory Support, CRF; Andrew Hack, MD, PhD, Managing Director, Bain Capital; Robert Schwartz, MD, President of the Jon DeHaan Foundation; James Eadie, MD, Managing Director of Sante Ventures; and Chaim S. Lotan, MD, Director, Innovations in Cardiovascular Interventions.
For more information: https://tct2022.crfconnect.com/
Related coverage:
November 03, 2022 
